Sequenom Company Profile (NASDAQ:SQNM)

About Sequenom (NASDAQ:SQNM)

Sequenom logoSequenom, Inc. is a life sciences company. The Company serves patients and physicians by providing early patient management information. The Company operates through Sequenom Laboratories segment. It conducts its business as a molecular diagnostics clinical laboratory located in San Diego, California and Raleigh-Durham, North Carolina. Its testing focus is on prenatal health that includes molecular-based laboratory developed tests (LDTs). The Company's diagnostic services are provided through its subsidiary, Sequenom Center for Molecular Medicine LLC (SCMM), doing business as Sequenom Laboratories. Sequenom Laboratories develops and validates its tests to be used as a testing service to physicians. Sequenom Laboratories is focused on developing and offering a menu of tests for prenatal continuum of care. The Sequenom Laboratories' test offerings in the prenatal market include MaterniT21 PLUS LDT, HerediT CF test, SensiGene RhD test, VisibiliT test and Test Send-out Agreements.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Diagnostic & Testing Equipment
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NASDAQ:SQNM
  • CUSIP: 81733740
  • Web: https://www.sequenom.com/
Average Prices:
  • 50 Day Moving Avg: $2.16
  • 200 Day Moving Avg: $1.47
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -18.38
  • P/E Growth: 0.00
Profitability:
  • Net Margins: -21.54%
  • Return on Assets: -25.05%
Debt:
  • Debt-to-Equity Ratio: -2.35%
  • Current Ratio: 3.35%
  • Quick Ratio: 3.16%
Misc:
  • Beta: 1.17
 

Frequently Asked Questions for Sequenom (NASDAQ:SQNM)

What is Sequenom's stock symbol?

Sequenom trades on the NASDAQ under the ticker symbol "SQNM."

How were Sequenom's earnings last quarter?

Sequenom, Inc. (NASDAQ:SQNM) issued its quarterly earnings results on Wednesday, May, 4th. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.10) by $0.01. The firm had revenue of $27.57 million for the quarter, compared to analyst estimates of $27.85 million. The business's revenue was down 27.1% on a year-over-year basis. During the same quarter last year, the firm earned $0.11 earnings per share. View Sequenom's Earnings History.

Who are some of Sequenom's key competitors?

How do I buy Sequenom stock?

Shares of Sequenom can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sequenom's stock price today?

One share of Sequenom stock can currently be purchased for approximately $2.39.


MarketBeat Community Rating for Sequenom (NASDAQ SQNM)
Community Ranking:  2.8 out of 5 ( )
Outperform Votes:  152 (Vote Outperform)
Underperform Votes:  115 (Vote Underperform)
Total Votes:  267
MarketBeat's community ratings are surveys of what our community members think about Sequenom and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Sequenom (NASDAQ:SQNM) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Sequenom (NASDAQ:SQNM)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/20/2016Jefferies Group LLCReiterated RatingHold$1.50 -> $0.75N/AView Rating Details
6/29/2016William BlairReiterated RatingMarket PerformN/AView Rating Details
3/3/2016Piper Jaffray CompaniesReiterated RatingHold$2.10N/AView Rating Details
3/3/2016Ladenburg Thalmann Financial ServicesUpgradeSell -> NeutralN/AView Rating Details
11/25/2015WedbushReiterated RatingNeutral$1.50N/AView Rating Details
(Data available from 7/21/2015 forward)

Earnings

Earnings History for Sequenom (NASDAQ:SQNM)
Earnings by Quarter for Sequenom (NASDAQ:SQNM)
Earnings History by Quarter for Sequenom (NASDAQ SQNM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/4/2016Q116($0.10)($0.11)$27.85 million$27.57 millionViewN/AView Earnings Details
3/2/2016Q415($0.10)($0.10)$29.35 million$27.80 millionViewN/AView Earnings Details
11/4/2015Q315($0.09)($0.08)$31.35 million$29.90 millionViewN/AView Earnings Details
8/5/2015Q215($0.05)($0.08)$35.74 million$32.77 millionViewN/AView Earnings Details
5/6/2015Q115($0.03)$0.12$38.60 million$37.80 millionViewN/AView Earnings Details
3/4/2015Q414($0.05)$0.14$41.94 million$36.80 millionViewN/AView Earnings Details
11/4/2014Q314($0.09)($0.05)$42.80 million$37.90 millionViewN/AView Earnings Details
7/29/2014Q214($0.10)($0.07)$47.80 million$39.80 millionViewN/AView Earnings Details
5/1/2014Q114($0.14)($0.13)$46.06 million$46.30 millionViewN/AView Earnings Details
2/27/2014Q413($0.16)($0.16)$47.05 million$45.13 millionViewN/AView Earnings Details
11/7/2013Q313($0.22)($0.24)$40.56 million$43.90 millionViewN/AView Earnings Details
7/24/2013Q2 2013($0.22)($0.27)$46.25 million$24.50 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.23)($0.26)$38.29 million$38.50 millionViewN/AView Earnings Details
3/7/2013Q4 2012($0.22)($0.29)$32.02 million$33.67 millionViewN/AView Earnings Details
11/8/2012Q312($0.23)($0.26)$22.91 million$22.90 millionViewN/AView Earnings Details
7/26/2012($0.21)($0.26)ViewN/AView Earnings Details
5/3/2012($0.19)($0.22)ViewN/AView Earnings Details
3/7/2012($0.18)($0.22)ViewN/AView Earnings Details
11/3/2011($0.19)($0.19)ViewN/AView Earnings Details
8/4/2011($0.17)($0.21)ViewN/AView Earnings Details
5/5/2011($0.19)($0.13)ViewN/AView Earnings Details
3/8/2011($0.21)($0.27)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Sequenom (NASDAQ:SQNM)
2017 EPS Consensus Estimate: ($0.14)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.04)($0.04)($0.04)
Q2 20171($0.04)($0.04)($0.04)
Q3 20171($0.03)($0.03)($0.03)
Q4 20171($0.03)($0.03)($0.03)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Sequenom (NASDAQ:SQNM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Sequenom (NASDAQ:SQNM)
Insider Ownership Percentage: 3.10%
Institutional Ownership Percentage: 46.03%
Insider Trades by Quarter for Sequenom (NASDAQ:SQNM)
Institutional Ownership by Quarter for Sequenom (NASDAQ:SQNM)
Insider Trades by Quarter for Sequenom (NASDAQ:SQNM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/7/2016Corp Of America Hol LaboratoryMajor ShareholderBuy36,649,440$2.40$87,958,656.00View SEC Filing  
6/10/2016Carolyn BeaverCFOBuy30,000$1.10$33,000.00View SEC Filing  
6/9/2016Carolyn BeaverCFOBuy10,000$1.10$11,000.00View SEC Filing  
6/9/2016Jeffrey D LintonSVPBuy5,000$1.10$5,500.00View SEC Filing  
6/8/2016Den Boom Dirk VanCEOBuy40,000$1.09$43,600.00View SEC Filing  
5/11/2016Daniel S Md GrosuCMOBuy30,000$1.11$33,300.00View SEC Filing  
5/6/2016Den Boom Dirk VanCEOBuy30,000$1.13$33,900.00View SEC Filing  
5/6/2016Jeffrey D LintonSVPBuy10,000$1.15$11,500.00View SEC Filing  
1/4/2016Camber Capital Management LlcMajor ShareholderBuy665,435$1.62$1,078,004.70View SEC Filing  
12/16/2015Camber Capital Management LlcMajor ShareholderBuy468,000$1.30$608,400.00View SEC Filing  
12/15/2015Camber Capital Management LlcMajor ShareholderBuy20,000$1.41$28,200.00View SEC Filing  
12/14/2015Camber Capital Management LlcMajor ShareholderBuy448,000$1.30$582,400.00View SEC Filing  
12/10/2015Camber Capital Management LlcMajor ShareholderBuy791,565$1.30$1,029,034.50View SEC Filing  
10/8/2015Camber Capital Management LlcMajor ShareholderBuy1,650,090$1.96$3,234,176.40View SEC Filing  
3/10/2015William J WelchCEOBuy10,000$3.65$36,500.00View SEC Filing  
3/9/2015Carolyn BeaverCFOBuy10,000$3.60$36,000.00View SEC Filing  
3/6/2015Jeffrey D LintonSVPBuy10,000$3.64$36,400.00View SEC Filing  
11/29/2012Goldman Myla LaiDirectorBuy4,000$4.59$18,360.00View SEC Filing  
11/26/2012John A FazioDirectorBuy2,000$4.45$8,900.00View SEC Filing  
8/8/2012Charles P SlacikDirectorBuy5,000$3.24$16,200.00View SEC Filing  
8/7/2012John A FazioDirectorBuy2,000$3.33$6,660.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Sequenom (NASDAQ:SQNM)
Latest Headlines for Sequenom (NASDAQ:SQNM)
Source:

Social

Chart

Sequenom (SQNM) Chart for Friday, July, 21, 2017

This page was last updated on 7/21/2017 by MarketBeat.com Staff